CareLoop.

The problem

Non-resident Indians supporting aging parents remotely live with chronic anxiety and a fragile, cobbled-together system of WhatsApp threads, Google Docs medication charts, and periodic calls. When a parent visits a doctor, the NRI child often hears only a vague "doctor said all fine" — while a doubled medication dose, a time-sensitive test, or an urgent warning never reaches them.

This matters because the language barrier between local-language doctors and English-speaking children is real, medication non-adherence runs 60–75% among elderly with chronic disease, and prescription deviations from standard guidelines occur in 45% of cases per ICMR 2024. Parents systematically hide problems, so passive detection and accurate visit records are essential.

The solution

CareLoop is a care-coordination platform that replaces ad hoc tools with a single dashboard for siblings across time zones — daily check-ins, medication updates, wearable signals, and family messaging. Its flagship AI feature is DocBridge, a doctor-visit companion.

A parent taps "Start Record" and, within minutes, the child receives a structured English summary: what the doctor found, what action is needed, a prescription table flagging dose changes as NEW / INCREASED / DECREASED / STOPPED, and any buried warning surfaced as a ⚠️ URGENT red alert rather than a forgotten mumble. It is positioned as an informational translation and summarization tool — not a medical device and not medical advice.

How it works

DocBridge runs a two-stage pipeline, both stages inside Azure Central India to satisfy DPDPA data residency so no health audio or transcript leaves the country. First, Azure AI Speech performs multilingual ASR with mid-conversation language detection, Hindi-English code-switching, and speaker diarization. Second, Azure OpenAI (GPT) handles translation, prescription extraction, change-vs-prior comparison, and STG-deviation checks against ICMR/NLEM/WHO in one structured call returning a four-section output.

Safety rules are strict: never invent or guess a dosage — flag it [unclear] instead — never give medical advice, and always include a disclaimer. RAG is not used in v1; the STG check relies on the model's parametric knowledge constrained by a version-controlled ruleset plus weekly pharmacist audit. The launch gate is three hard-block metrics: Dosage Fidelity ≥99.5%, hallucination avoidance, and 100% safety-guardrail pass — any single failure blocks launch.

Who it's for

The target buyer and power user is "The Anxious NRI Child" — an Indian-origin professional aged 30–55 in the US, UK, Canada, Australia, or the Middle East, carrying persistent guilt and the dread of the middle-of-the-night call. The monitored end user is the aging parent in a Tier-1 or Tier-2 Indian city, who interacts through simplified interfaces.

The model is B2C with tiered subscriptions (Basic, Premium, Concierge), where DocBridge sits in the higher tiers, plus a B2B2C growth channel through NRI banking, hospitals, and senior-living partners.

Why it matters

The global elder-care technology market is projected to grow at a 15–20% CAGR over 2025–2030, and India's 60+ population is set to nearly double to 347 million by 2050. The NRI segment is especially attractive: 18M+ diaspora with incomes 3–5x the Indian median and acute, guilt-driven willingness to pay, against a target addressable market of 5–8M NRI families with parents 60+.

CareLoop's edge is a passive-monitoring-plus-human-escalation hybrid built NRI-native for cross-timezone, cross-currency realities. DocBridge directly attacks the 45% prescription-deviation problem and the doctor-to-child language gap, rolling out in staged, safety-gated phases from a free 1-year, ~50-family closed pilot toward paid tiers.

At a glance

Project

CareLoop

Built by

Ayon Gon

One-liner

CareLoop is a care coordination product for non-resident Indians trying to support aging parents remotely.